Targeted Medical Pharma, Inc. announced earnings results for second quarter and six months ended June 30, 2013. For the quarter, the company's total revenue was increased 32% to $1,917,388 compared to $1,448,226 in 2012. In addition, total gross profit for the quarter increased 43% to $1,181,918 in 2013 compared to $826,966 in 2012. This increase reflected a change in customer mix.

For the six months, the company's total revenue was increased 67% to $4,728,519 compared to $2,823,411 in first half of 2012. Furthermore, total gross profit for the quarter increased 97% to $3,094,375 in 2013 compared to $1,567,416 in 2012. The loss from operations decreased 29% to $2,326,320 compared to the loss from operations of $3,268,229 in 2012.